These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
528 related articles for article (PubMed ID: 18673415)
1. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma. Hoch BL; Wu M; Lewis M; Gan L; Burstein DE J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415 [TBL] [Abstract][Full Text] [Related]
2. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Altemani A; Martins MT; Freitas L; Soares F; Araújo NS; Araújo VC Histopathology; 2005 Jun; 46(6):635-41. PubMed ID: 15910594 [TBL] [Abstract][Full Text] [Related]
3. S100P expression in ductal type of carcinoma ex pleomorphic adenoma. Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Higaki Y; Komune S; Tsuneyoshi M; Oda Y Am J Surg Pathol; 2011 Mar; 35(3):346-55. PubMed ID: 21317706 [TBL] [Abstract][Full Text] [Related]
4. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry. Di Palma S; Skálová A; Vanìèek T; Simpson RH; Stárek I; Leivo I Histopathology; 2005 Feb; 46(2):144-52. PubMed ID: 15693886 [TBL] [Abstract][Full Text] [Related]
5. Immunoprofile of reactive salivary myoepithelial cells in intraductal areas of carcinoma ex-pleomorphic adenoma. de Araújo VC; Altemani A; Furuse C; Martins MT; de Araújo NS Oral Oncol; 2006 Nov; 42(10):1011-6. PubMed ID: 16757205 [TBL] [Abstract][Full Text] [Related]
6. Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation. Demasi AP; Furuse C; Soares AB; Altemani A; Araújo VC Hum Pathol; 2009 Mar; 40(3):390-7. PubMed ID: 18992915 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma. Katori H; Nozawa A; Tsukuda M Auris Nasus Larynx; 2007 Mar; 34(1):79-84. PubMed ID: 17049779 [TBL] [Abstract][Full Text] [Related]
9. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Lewis JE; Olsen KD; Sebo TJ Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714 [TBL] [Abstract][Full Text] [Related]
10. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma. Katori H; Nozawa A; Tsukuda M Acta Otolaryngol; 2007 Nov; 127(11):1207-13. PubMed ID: 17851915 [TBL] [Abstract][Full Text] [Related]
11. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma. de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of X-linked inhibitor of apoptosis in head and neck squamous cell carcinoma. Nagi C; Xiao GQ; Li G; Genden E; Burstein DE Ann Diagn Pathol; 2007 Dec; 11(6):402-6. PubMed ID: 18022123 [TBL] [Abstract][Full Text] [Related]
13. Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy. Félix A; Rosa JC; Fonseca I; Cidadão A; Soares J Histopathology; 2004 Aug; 45(2):187-92. PubMed ID: 15279638 [TBL] [Abstract][Full Text] [Related]
14. Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma. Soares AB; Ponchio L; Juliano PB; de Araújo VC; Altemani A J Clin Pathol; 2007 Sep; 60(9):995-1000. PubMed ID: 17079351 [TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands. de Souza AA; Altemani A; Passador-Santos F; Turssi CP; de Araujo NS; de Araújo VC; Soares AB Virchows Arch; 2015 Sep; 467(3):295-301. PubMed ID: 26155914 [TBL] [Abstract][Full Text] [Related]
16. Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome. Sedassari BT; Rodrigues MFSD; Conceição TS; Mariano FV; Alves VAF; Nunes FD; Altemani A; de Sousa SCOM Virchows Arch; 2017 Dec; 471(6):775-784. PubMed ID: 28842747 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of p63 and XIAP in thymic hyperplasia and thymomas. Wu M; Sun K; Gil J; Gan L; Burstein DE Am J Clin Pathol; 2009 May; 131(5):689-93. PubMed ID: 19369629 [TBL] [Abstract][Full Text] [Related]
18. Expression of betacatenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: an immunohistochemical study. do Prado RF; Consolaro A; Taveira LA Med Oral Patol Oral Cir Bucal; 2006 May; 11(3):E247-51. PubMed ID: 16648762 [TBL] [Abstract][Full Text] [Related]
19. Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53. Ihrler S; Weiler C; Hirschmann A; Sendelhofert A; Lang S; Guntinas-Lichius O; Arnold G; Zietz C; Harrison JD Histopathology; 2007 Sep; 51(3):362-71. PubMed ID: 17593217 [TBL] [Abstract][Full Text] [Related]
20. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review]. Stodulski D; Rzepko R; Kowalska B; Stankiewicz C Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]